California National Primate Research Center
California National Primate Research Center
批准号:
10555821
负责人:
Simon J. Atkinson
金额:
$1185.79万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-05-01 至 2028-04-30
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseAnatomyAnimal ExperimentationAnimalsAppointmentAreaBehaviorBiological AssayBiomedical ResearchCOVID-19CaliforniaCaringClinical PathologyCollaborationsCommunicable DiseasesCommunitiesCore FacilityDedicationsDevelopmentDiseaseEducation and OutreachElderlyEnsureFlow CytometryFosteringFundingGeneticGoalsGrantGrowthHealthHealth ServicesHumanInformation TechnologyInfrastructureInhalation ExposureInstitutionKnowledgeLaboratoriesLeadLongevityMedicalMedicineMentorsMissionModelingMultimodal ImagingNational Institute on AgingNeurosciencesPreventionPrimatesQuality of lifeRegenerative MedicineReproductive SciencesResearchResearch DesignResearch PersonnelResearch PriorityResearch SupportResourcesRoleSchoolsScienceScientistServicesSiteTrainingUnited States National Institutes of HealthUniversitiesVeterinariansVisionZIKAZika Virusanimal carebasebehavioral healthbiobehaviorcareercollegefightinghigh standardhuman diseaseimprovedindustry partnernext generationnonhuman primateoperationoutreachpopulation healthprogramspsychologicrecruitresponsible research conducttooltranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
OVERALL: CALIFORNIA NATIONAL PRIMATE RESEARCH CENTER
ABSTRACT
The California National Primate Research Center (CNPRC), located at the University of California, Davis,
requests funds to renew the base operating grant #P51-OD011107 for the next five-year period (May 1, 2023
through April 30, 2028). Currently in the 60th year of operation, the CNPRC serves a range of NIH-supported
investigators and industry partners nationwide. From inception through the current year, the CNPRC has been
highly responsive to the research community by providing high quality animals, facilities, tools, and services
driven by the intellectual infrastructure of the Core Scientists in the service of our Mission: “To improve human
health and quality of life through support of exceptional nonhuman primate research programs”. The
supplemental funds requested fits within the following Specific Aims: (1) Conduct state-of-the-art research and
scientifically contribute to the understanding and treatment of human disease with nonhuman primate models
across the life span, (2) Provide exceptional nonhuman primate expertise and services to investigators at the
local, regional, and national levels to advance NIH-supported research excellence, (3) Mentor and train the next
generation of translational investigators with nonhuman primate expertise and inform the public regarding the
importance and translational power of the nonhuman primate model, and (4) Ensure the highest standards of
responsible conduct of research and animal care. We will continue to emphasize team science aimed at major
human health problems across the lifespan, with the goal of moving beyond traditional interdisciplinary efforts to
true convergence on the research problems being addressed. Support is requested for Administrative Services
(Administration and Operations Services, Director’s Office, Information Technology Services), Alterations and
Renovations (Facilities Improvement), Colony Management Unit (Anatomic and Clinical Pathology Services,
Animal Care and Research Services, BioBehavioral Assessment, Genetics Management Services National
Institute on Aging Colony, Population and Behavioral Health Services, and Primate Medicine Services), Service
Cores (Flow Cytometry, Inhalation Exposure, Multimodal Imaging, Primate Assay Laboratory), Scientific
Research Units (Cardiorespiratory Diseases, Infectious Diseases, Neuroscience and Behavior, and
Reproductive Sciences and Regenerative Medicine), Outreach/Public Information Office, and the Pilot Research
Program. We are committed to developing and providing a wide range of research opportunities that maximize
use of the nonhuman primate model to improve human health. The institutional commitment from UC Davis to
the CNPRC is outstanding and will continue to facilitate our role in moving nonhuman primate research into the
next era of translational biomedical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8107323
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8470639
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8675226
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8318626
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7990218
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2009
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:8069200
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7899725
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:8274881
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7382355
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7856981
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rac2 in reglation of cytoskeletal function
-
批准号:6595711
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2002
-
负责人:Simon J. Atkinson
-
依托单位:
Core--Imaging
-
批准号:6595717
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2002
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7409893
-
项目类别:
-
资助金额:$36.54万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6177991
-
项目类别:
-
资助金额:$21.05万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6617845
-
项目类别:
-
资助金额:$23.0万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6523695
-
项目类别:
-
资助金额:$22.33万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6381050
-
项目类别:
-
资助金额:$21.68万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:2908123
-
项目类别:
-
资助金额:$20.5万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: